Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Cancer

Explore clinical trials studying Pancreatic Cancer. Study availability and eligibility vary by location and protocol.

1,289 public trials 284 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Cancer trial results

Completed

Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer

NCT00789633

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Eastern Connecticut Hematology and Oncology (ECHO) Norwich, Connecticut, United States
  • MD Anderson Orlando, Florida, United States
  • The Emory Clinic Atlanta, Georgia, United States
  • Decatur Memorial Hospital Decatur, Illinois, United States
View all 68 locations
View Trial Details
Completed

hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse

NCT02960594

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Cancer, +53 more
Locations
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer

NCT00068432

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Hembree Mercy Cancer Center at St. Edward Mercy Medical Center Fort Smith, Arkansas, United States
  • M.D. Anderson Cancer Center - Orlando Orlando, Florida, United States
  • CCOP - Atlanta Regional Atlanta, Georgia, United States
  • CCOP - Carle Cancer Center Urbana, Illinois, United States
View Trial Details
Completed

Gemcitabine, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery

NCT01032057

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust Birmingham, England, United Kingdom
  • Bristol Haematology and Oncology Centre Bristol, England, United Kingdom
  • Addenbrooke's Hospital Cambridge, England, United Kingdom
  • Queen Alexandra Hospital Cosham, England, United Kingdom
View all 26 locations
View Trial Details
Completed

A Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer

NCT02399137

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations
  • Banner MD Anderson Cancer Ctr. Gilbert, Arizona, United States
  • Pacific Cancer Medical Center, Inc. Anaheim, California, United States
  • St. Jude Heritage Healthcare Fullerton, California, United States
  • UCLA School of Medicine Los Angeles, California, United States
View all 66 locations
View Trial Details

Related conditions